4Yang W,Lu J,Weng J,et al.Prevalence of diabetes among men and women in China[J].N Engl J Med,2010,362(12):1090-1101.
5Soran H,Younis N.Insulin detemir:a new basal insulin analogue[J].Diabetes Obes Metab,2006,8(1):26-30.
6Dornhorst A,Lüddeke HJ,Honka M,et al.Safety and efficacy of insulin detemir basal-bolus therapy in type 1 diabetes patients:14-week data from the European cohort of the PREDICTIVE study[J].Curr Med Res Opin,2008,24(2):369-376.
7Dornhorst A,Lüddeke HJ,Sreenan S,et al.Safety and efficacy of insulin detemir in clinical practice:14-week follow-up data from type 1 and 2 diabetes patients in the PREDICTIVE European cohort[J].Int J Clin Pract,2007,61(3):523-528.
8Kurtzhals P,Sch(a)ffer L,Sφrensen A,et al.Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use[J].Diabetes,2000,49(6):999-1005.
9Yang W, Lu J, Weng J, et al. Prevalence of diabetes amongmen and women in China. N Engl J Med, 2010, 362(12):1090-1101.
10Ardawi MS,Akhbar DH,Alshaikh A. Increased serum sclerostin and decreased serum IGF 1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes[J].{H}BONE,2013,(02):355-362.
